Current Report Filing (8-k)
December 09 2022 - 12:51PM
Edgar (US Regulatory)
0000796505
false
0000796505
2022-12-06
2022-12-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December
6, 2022
CLEARFIELD,
INC.
(Exact Name of Registrant as Specified in Charter)
Minnesota
(State or Other Jurisdiction of Incorporation)
000-16106 |
41-1347235 |
(Commission File No.) |
(IRS Employer Identification No.) |
7050
Winnetka Avenue North, Suite
100, Brooklyn
Park, MN
55428
(Address of Principal Executive Offices)(Zip Code)
(763)
476-6866
(Registrant’s Telephone Number, Including Area Code)
Not
Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol |
Name of each exchange on which registered |
Common
Stock, $0.01 par value |
CLFD |
The
NASDAQ Stock Market |
Indicate by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of
1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use
the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. ☐
Items under Sections 2 through 7 are not applicable and therefore omitted.
|
Item 1.01. |
Entry into a Material Definitive Agreement. |
On December 6, 2022, Clearfield, Inc. (the “Company”) entered
into an Underwriting Agreement (the “Underwriting Agreement”) with Cowen and Company, LLC and Needham & Company, LLC,
each acting as representative of the several other underwriters named therein (collectively, the “Underwriters”), in connection
with the underwritten public offering by the Company (the “Offering”) of 1,200,000 shares (the “Shares”) of the
Company’s common stock, $0.01 par value (“Common Stock”). The Company sold the Shares to the Underwriters at a price
of $94.50. The price to the public in the Offering was $100.00 per share. In addition, the Company granted the Underwriters an option
for a period of 30 days from the date of the Underwriting Agreement to purchase an additional 180,000 shares of Common Stock on the same
terms and conditions. On December 8, 2022, the Underwriters exercised in full their option to purchase the additional 180,000 shares of
Common Stock.
The Offering closed on December 9, 2022. At the closing, the Company sold
1,380,000 shares of Common Stock for net proceeds to the Company of $130,410,000 before expenses paid by the Company in connection with
the Offering. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes.
The Offering was made pursuant to the Company’s automatic shelf registration
statement on Form S-3 (File No. 333-264533) (the “Registration Statement”) filed with the Securities and Exchange Commission
(the “SEC”) on April 28, 2022, which became effective upon filing. The Company filed a preliminary prospectus supplement and
final prospectus supplement with the SEC in connection with the Offering on December 6, 2022 and December 8, 2022, respectively.
The Company made certain customary representations, warranties and covenants
in the Underwriting Agreement concerning the Company and the Registration Statement, the preliminary prospectus supplement, and the final
prospectus supplement. The Company has also agreed to indemnify the Underwriters against certain liabilities, including liabilities under
the Securities Act of 1933, as amended. In addition, pursuant to the terms of the Underwriting Agreement, the executive officers and directors
of the Company have entered into “lock-up” arrangements with the Underwriters, which generally prohibit the sale, transfer
or other disposition of securities of the Company for a 90-day period following the date of the Underwriting Agreement, subject to certain
exceptions.
The foregoing description of the Underwriting Agreement is not complete and
is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is attached to this Current Report on
Form 8-K as Exhibit 1.1 and incorporated by reference herein. A copy of the opinion of Ballard Spahr LLP relating to the validity of the
Shares issued in the Offering is filed herewith as Exhibit 5.1.
This Current Report on Form 8-K does not constitute an offer to sell or a solicitation of an
offer to buy the securities discussed herein, and there shall not be any sale of such shares in any state or jurisdiction in which such
an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
The sale of shares of the Company’s Common Stock is being made only by means of a prospectus and related prospectus supplement.
On December 6, 2022, the Company issued a press release announcing the commencement
of the Offering, and, on December 6, 2022, the Company issued a press release announcing the pricing of the Offering. Copies of such press
releases are attached to this Current Report on Form 8-K as Exhibits 99.1 and 99.2, respectively.
|
Item 9.01. |
Financial Statements and Exhibits. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
CLEARFIELD, INC. |
|
|
|
|
By: |
/s/ Cheryl Beranek |
Dated: December 9, 2022 |
|
Cheryl Beranek, Chief Executive Officer |
Clearfield (NASDAQ:CLFD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clearfield (NASDAQ:CLFD)
Historical Stock Chart
From Jul 2023 to Jul 2024